Loading clinical trials...
Loading clinical trials...
The Progression From Dysmenorrhoea to Chronic Pelvic Pain: Investigation of the Role of Chronic Inflammatory Pain Phenotype in Peripheral Blood as a Potential Biomarker.
This is a cross-sectional observational study. For participants resident in Adelaide, South Australia. The study consists of 3 visits to the Pain and Anaesthesia Research Clinic (PARC), within the Royal Adelaide Hospital (RAH). A total of 56 participants will be recruited for this study.
The study will involve a screening visit followed by two visits to PARC for blood sampling and questionnaires. At the baseline visit, blood samples to assess biomarkers and confirm hormonal status will be taken. From screening until the final study visit a total of approximately 120 mL in blood samples will be taken from each participant. The study aims to further knowledge in the presence of severe pelvic pain in young women which is an area that has been under-researched with regard to it's impact on society. The study proposes to enroll 7 groups of 8 healthy nulliparous women aged 18-35 with the following characteristics: Mild or absent dysmenorrhoea (pain scale 0-3) and no other pelvic pain symptoms. (3 groups) * Group 1, without contraceptive pill use * Group 2A , contraceptive pill user and with a history of mild or absent dysmenorrhoea prior to pill use * Group 2B, contraceptive pill user and with a history of severe dysmenorrhoea (pain scale 7-10) prior to pill use Severe dysmenorrhoea (pain scale 7-10), but without chronic pelvic pain. (2 groups) * Group 3, without contraceptive pill use * Group 4, contraceptive pill user Chronic pelvic pain and severe dysmenorrhoea (2 groups) * Group 5, without contraceptive pill use * Group 6,contraceptive pill user
Age
16 - 35 years
Sex
FEMALE
Healthy Volunteers
Yes
PARC, Royal Adelaide Hospital
Adelaide, South Australia, Australia
Start Date
November 1, 2014
Primary Completion Date
January 1, 2016
Completion Date
January 1, 2016
Last Updated
March 28, 2025
56
ACTUAL participants
OCPs
DRUG
Lead Sponsor
University of Adelaide
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06587607